Neurosurgical device manufacturer NICO Corporation and surgical ultrasound leader Hitachi Aloka Medical America, Inc. have collaborated to provide neurosurgeons real-time, intraoperative imaging to assist with greater extent of resection when accessing brain tumors using the NICO BrainPath.

In the U.S. alone, nearly 500,000 patients are diagnosed each year with brain abnormalities such as tumors and hemorrhagic stroke. Due to the location of the abnormality and the complex nature of the brain, over 50 percent of those patients have few, if any, effective surgical treatment options. While surgical resection followed by adjuvant therapy is considered the gold standard for neurosurgical treatment of brain tumors, the risks of debilitating deficits has been too great until now to attempt many of these surgeries.

A unique surgical approach to these subcortical abnormalities using the BrainPath has been used in over 2,500 procedures at over 60 institutions throughout the United States. In some cases, visualization of the tumor can be difficult without creating a larger access point, increasing the chances of deficits. The new Hitachi Aloka ultrasound probe, still under development, is specifically designed for use with the BrainPath. It uses ultrasound technology to assist surgeons in precisely and efficiently locating tumors beyond their direct vision in the surgical field. Both companies are attending the 2015 Congress of Neurological Surgeons this week, NICO in booth #116 and Hitachi Aloka Medical in booth #1137.

This collaboration comes just one month after NICO announced that, based on the evaluation of the clinical effectiveness and documented patient outcomes when using BrainPath, the Food and Drug Administration (FDA) granted the BrainPath clearance for specific indications for subcortical access to brain tumors, cysts and vascular disease. These developments, combined with the more than 300 neurosurgeons, residents and fellows now trained on BrainPath, help clear the way for surgeons to use these technologies for the greater benefit of patients.

David Famiglietti, president and GM of Hitachi Aloka Medical America, said Hitachi Aloka Medical’s ultrasound imaging is being used by surgeons in various disciplines to improve accuracy and precision during the resection of tumors.

NICO Corporation
www.NICOneuro.com